MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$120,073K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of shor...
Share-based compensation expense
Accrued expenses and other curre...
Others
Negative Cash Flow Breakdown
Net loss
Purchases of short-term investme...
Other non-current assets
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-106,159
-75,968
33,004
-65,712
Share-based compensation expense
12,634
11,639
8,069
7,495
Depreciation expense
551
576
412
356
Accretion of asset retirement obligation
19
10
322
23
Non-cash lease expense
745
639
618
621
Accretion of net investment discounts
3,392
3,246
2,759
3,291
Gains on sale of non-financial assets
-
-
10,249
-
Other receivable
0
-100,000
100,000
-
Prepaid expenses and other current assets
-2,724
7,988
9,127
2,177
Other non-current assets
35,440
4,838
-5,882
397
Accounts payable
3,309
-4,967
-5,007
8,806
Accrued expenses and other current liabilities
5,513
-134
15,022
3,881
Operating lease liabilities
-763
-695
-603
-601
Other non-current liabilities
144
206
-
-
Net cash used in operating activities
-120,115
15,234
-64,416
-50,996
Purchases of short-term investments
44,633
647,468
93,623
248,824
Proceeds from maturities of short-term investments
119,091
151,703
146,168
195,919
Purchases of property and equipment
-42
1,182
1,496
1,572
Advance payment received for sale of non-financial asset
-
-
-
5,158
Proceeds from sale of non-financial asset
-
-
10,249
-
Net cash (used in) provided by investing activities
74,500
-496,947
56,140
-49,319
Proceeds from issuance of ordinary shares-At Market Common Stock Offering Program
-
-
0
57,058
Proceeds from issuance of ordinary shares-Follow On Offering
-
-
608,650
-
Proceeds from issuance of pre-funded warrants in 2025 follow-on offering, net of underwriting discounts and commissions
-
-
94,000
-
Payments of offering costs
0
37
1,250
770
Proceeds from issuance of ordinary shares under employee share purchase plan
872
-
447
0
Proceeds from exercise of share options
1,213
869
3,140
377
Payment of taxes on restricted share units withheld for taxes
0
2,574
0
462
Net cash provided by financing activities
2,085
-1,742
704,987
56,203
Net change in cash and cash equivalents
-43,530
-483,455
696,711
-44,112
Beginning of the period
316,168
799,623
102,912
169,510
End of the period
272,638
316,168
799,623
102,912
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of short-term...
$119,091K
(-58.71%↓ Y/Y)
Proceeds from exercise of
share options
$1,213K
(20.34%↑ Y/Y)
Proceeds from issuance of
ordinary shares under...
$872K
(83.97%↑ Y/Y)
Purchases of property and
equipment
-$42K
(-107.69%↓ Y/Y)
Net cash (used in)
provided by investing...
$74,500K
(-10.21%↓ Y/Y)
Net cash provided by
financing activities
$2,085K
(57.24%↑ Y/Y)
Canceled cashflow
$44,633K
Net change in cash
and cash...
-$43,530K
(-93.59%↓ Y/Y)
Canceled cashflow
$76,585K
Share-based compensation
expense
$12,634K
(-5.91%↓ Y/Y)
Accrued expenses and
other current...
$5,513K
(111.15%↑ Y/Y)
Accounts payable
$3,309K
(242.55%↑ Y/Y)
Prepaid expenses and
other current assets
-$2,724K
(-153.32%↓ Y/Y)
Non-cash lease expense
$745K
(-23.35%↓ Y/Y)
Depreciation expense
$551K
(-2.48%↓ Y/Y)
Other non-current
liabilities
$144K
Accretion of asset
retirement obligation
$19K
Purchases of short-term
investments
$44,633K
(-78.22%↓ Y/Y)
Net cash used in
operating activities
-$120,115K
(-12.48%↓ Y/Y)
Canceled cashflow
$25,639K
Net loss
-$106,159K
(2.15%↑ Y/Y)
Other non-current
assets
$35,440K
(3133.58%↑ Y/Y)
Accretion of net
investment discounts
$3,392K
(-64.43%↓ Y/Y)
Operating lease
liabilities
-$763K
(30.13%↑ Y/Y)
Buy us a coffee
Structure Therapeutics Inc. (GPCR)
Structure Therapeutics Inc. (GPCR)